Streetbeat News

Legal

NYT

The New York Times (NYT) is developing a generative AI (GenAI) ad-targeting tool, set to debut in the second half of the year. This tool, created internally, aims to optimize ad placements based on campaign objectives and target niche audiences. The NYT is currently recruiting advertising partners for a closed beta test starting next quarter. The tool leverages large language models (LLMs) and is part of the NYT's broader investment in GenAI technology, despite its lawsuit against OpenAI and Microsoft for copyright infringement.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 2:55 pm

EVLV

Evolv Technology defends its security technology against short seller accusations, emphasizing its commitment to safety and the effectiveness of its Evolv Express solution. The company refutes claims about its testing, weapon detection capabilities, and customer satisfaction, citing extensive third-party testing, successful weapon detections, and high throughput rates. Evolv highlights its technology's real-world performance and the trust placed in it by security professionals and customers across various industries.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 2:52 pm

AMH

AVB

SPY

The U.S. Supreme Court has decided not to hear a challenge by landlords against rent stabilization laws, leaving the current regulations in place. This decision affects various real estate investment trusts (REITs) and the broader market, as indicated by the mention of SPY, which tracks the S&P 500.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 2:34 pm

BJ

STZ

Constellation Brands, Inc. (NYSE:STZ) announced the election of Christopher J. Baldwin as the new non-executive chair of the board, effective March 1, 2024. Baldwin, a managing partner at CVC Advisors and former executive at BJ's Wholesale Club Holdings Inc. (NYSE:BJ), brings extensive experience in consumer packaged goods and retail industries. The board also accepted the resignation of Susan Somersille Johnson, effective February 17, 2024. These changes are part of Constellation's ongoing board refreshment and governance enhancement process.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:55 pm

MMAT

Meta Materials has been granted U.S. Patent # D1015424, covering a wide range of documents and packages with a new security feature. This patent encompasses banknotes, identification cards, passports, checks, security documents, government stamps, vehicle registrations, and packages, indicating a significant advancement in security technology.

Portfolio Pulse from Charles Gross

February 20, 2024 | 1:40 pm

LTRY

Lottery.com Inc. announced the voluntary dismissal of a lawsuit by Woodford Eurasia Assets alleging proxy misstatements against the company and its directors. The lawsuit, filed in the United States District Court for the District of Delaware, was dismissed without prejudice. This legal action initially sought to prevent a special meeting of stakeholders regarding the sale of stock to United Capital Investments London Limited, which could change company control. The court had previously denied Woodford's motion for a temporary restraining order and injunction. With the lawsuit's dismissal, Lottery.com focuses on its mission in the lottery and sports media industries.

Portfolio Pulse from Happy Mohamed

February 20, 2024 | 1:12 pm

MEOH

Methanex Corporation announced a delay in the commercial production of its new Geismar 3 methanol plant in Louisiana due to complications in the autothermal reformer during start-up. Significant damage to refractory bricks requires replacement, potentially delaying production until the end of Q3 2024. The issue is attributed to the start-up process, not plant design or construction, and is not expected to significantly exceed the $1.30 billion capital cost guidance.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:06 pm

MSFT

OpenAI's Sora, despite its impressive debut, has shown weaknesses in video generation, such as adding extra limbs to subjects or misrepresenting physical interactions. These issues highlight the AI's current limitations in understanding complex scenes and physics. Microsoft Corp. (NASDAQ:MSFT), a backer of OpenAI, acknowledges these challenges. Amidst its development, concerns about misuse, especially in the context of upcoming elections, are rising. However, these imperfections could help distinguish AI-generated content from real footage.

Portfolio Pulse from Rounak Jain

February 20, 2024 | 12:53 pm

META

Veteran trader Peter Brandt suspects his posts on X (formerly Twitter) are being censored due to his views on voting and COVID fraud, inspired by an interview with Mike Benz. Elon Musk has also accused Meta Platforms Inc. (META) of censorship, particularly around election integrity.

Portfolio Pulse from Benzinga Neuro

February 20, 2024 | 12:39 pm

RAPT

Rapt Therapeutics has been informed by the FDA of a clinical hold on its Phase 2B trial of Zelnecirnon in atopic dermatitis and its Phase 2A trial in asthma due to a serious adverse event of liver failure in one patient. Dosing and enrollment have been halted in both trials. The hold does not affect RAPT's oncology trial of tivumecirnon.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:35 pm